KEGG: slo:Shew_3375
STRING: 323850.Shew_3375
UbiB is classified as a probable ubiquinone biosynthesis protein in Shewanella loihica. It belongs to the UbiB family of proteins that are involved in the biosynthesis of ubiquinone (Coenzyme Q), a redox-active lipid essential for oxidative phosphorylation in cellular respiration . The exact biochemical function of UbiB in the pathway remains under investigation, but research suggests that UbiB proteins, like their yeast homolog Coq8, are required for coenzyme Q biosynthesis and likely function in the conversion process of aromatic precursors to the ubiquinone head group . Coenzyme Q is particularly essential for the mitochondrial respiratory chain function, serving as an electron carrier that enables efficient energy production .
The recombinant UbiB protein from Shewanella loihica is available as a partial protein with UniProt accession number A3QIE3 . The protein has a purity of >85% as determined by SDS-PAGE analysis and is produced in mammalian cells, which may provide certain post-translational modifications different from bacterial expression systems . While specific structural elements such as binding domains are not fully characterized in the search results, understanding the protein's structure is critical for functional studies. Computational approaches similar to those used for related enzymes like Coq6 could be applied to predict structural features, including potential substrate access channels and binding sites .
Shewanella loihica produces ubiquinones consisting mainly of Q-7 and Q-8, along with menaquinone MK-7 . This ubiquinone profile may differ from other bacterial species, reflecting adaptations to its unique ecological niche. The presence of both ubiquinones and menaquinones suggests versatility in electron transport chains, potentially contributing to the organism's ability to thrive in varied environments. While the UbiB protein is part of a conserved family found across different species (including homologs like Coq8 in yeast), the specific variants and their functional implications may vary between organisms . Understanding these differences requires comparative genomic and biochemical approaches to elucidate species-specific adaptations in ubiquinone biosynthesis pathways.
For optimal preservation of recombinant UbiB protein activity, specific storage conditions should be followed:
| Formulation | Recommended Storage | Shelf Life |
|---|---|---|
| Liquid form | -20°C/-80°C | 6 months |
| Lyophilized form | -20°C/-80°C | 12 months |
| Working aliquots | 4°C | Up to one week |
Repeated freezing and thawing cycles should be avoided as they can significantly decrease protein stability and activity . The shelf life is influenced by multiple factors including buffer composition, storage temperature, and the inherent stability of the protein itself . For long-term storage, preparing single-use aliquots containing glycerol as a cryoprotectant is recommended to maintain protein integrity.
The recommended reconstitution protocol for lyophilized UbiB protein involves several critical steps:
Briefly centrifuge the vial prior to opening to bring the contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (with 50% being the default recommendation)
Prepare aliquots for long-term storage at -20°C/-80°C
This reconstitution method helps maintain protein stability and prevents degradation during storage . The addition of glycerol serves as a cryoprotectant, reducing protein denaturation during freeze-thaw cycles and prolonging the functional lifespan of the protein. For specialized applications requiring alternative buffer systems, pilot experiments should be conducted to verify protein stability and activity in the new formulation.
Several complementary experimental approaches can be employed to characterize UbiB function:
Enzymatic assays: Developing activity assays based on potential substrates involved in ubiquinone biosynthesis
Structural studies: Utilizing techniques such as homology modeling, molecular dynamics simulations, and substrate docking calculations as demonstrated with related enzymes like Coq6
Chemical genetics: Employing specific inhibitors to probe protein function, similar to the COQ8 inhibitor TTP-UNC-CA157 that targets human COQ8 proteins
Protein-protein interaction studies: Using co-immunoprecipitation, yeast two-hybrid screens, or crosslinking coupled with mass spectrometry to identify interaction partners
Mutagenesis: Creating targeted mutations to investigate key residues involved in substrate binding or catalysis
The development of specific chemical tools to probe UbiB function would significantly advance understanding, as the lack of potent, selective inhibitors has hampered full characterization of UbiB proteins .
Shewanella loihica offers several advantages as a model organism for studying ubiquinone biosynthesis:
Natural ubiquinone production: It naturally synthesizes ubiquinones (primarily Q-7 and Q-8) and menaquinone MK-7, providing a native system for studying these pathways
Genomic characteristics: Its relatively compact genome of approximately 4.5 Mbp with 3,859 protein genes and 124 RNA genes facilitates genetic manipulation and analysis
Metabolic versatility: Being facultatively anaerobic, it allows for studies under both aerobic and anaerobic conditions, providing insights into respiratory chain adaptations
Environmental adaptation: Its psychrotolerant nature (growth at 0-42°C) permits investigation of temperature-dependent variations in membrane composition and respiratory components
Ecological relevance: Originally isolated from iron-rich microbial mats at a hydrothermal vent, it represents adaptations to extreme environments, potentially including specialized ubiquinone systems
These characteristics make Shewanella loihica an excellent model for understanding fundamental aspects of ubiquinone biosynthesis and its role in environmental adaptation.
While the search results don't provide specific optimized protocols for UbiB expression in Shewanella loihica, general growth conditions for the organism have been established. Shewanella loihica is psychrotolerant, capable of growing at temperatures ranging from 0-42°C, and is facultatively anaerobic . Growth on Luria–Bertani agar plates has been demonstrated, and the organism appears as orange, rod-shaped bacteria with dimensions of approximately 1.8 µm in length and 0.7 µm in width .
For studying UbiB expression specifically, researchers should consider:
Varying oxygen availability to examine effects on respiratory chain components
Testing different temperature conditions within the organism's growth range
Examining expression under different nutrient limitations or carbon sources
Monitoring growth phases to identify optimal UbiB expression timing
A methodical approach involving RT-PCR, western blotting, or reporter gene constructs could be employed to determine conditions that maximize UbiB expression for subsequent protein purification and functional studies.
Genomic approaches provide powerful tools for investigating UbiB in the context of Shewanella loihica's broader metabolic networks:
Comparative genomics: Analyzing UbiB conservation across the 49 Shewanella species with 248 available genomes could reveal species-specific adaptations in ubiquinone biosynthesis
Transcriptomic analysis: RNA-seq under different environmental conditions could identify co-regulated genes and regulatory networks involving UbiB
Proteogenomics approach: Integrating proteomic data with genomic information can improve annotation and identify potential post-translational modifications or alternative protein forms7
Targeted gene disruption: CRISPR-Cas9 or traditional homologous recombination approaches to create UbiB mutants and assess phenotypic consequences
Metabolomic profiling: Analyzing changes in ubiquinone and intermediate metabolites in wild-type versus UbiB-modified strains
The genomic data available for Shewanella loihica (4,602,594 nucleotides, 3,859 protein genes, and 124 RNA genes) provides a solid foundation for these approaches . Additionally, the relatively high GC content (53.7%) should be considered when designing primers or expression constructs .
Understanding UbiB's interactions with the coenzyme Q biosynthetic pathway requires a multi-faceted experimental approach:
Metabolic profiling: Using LC-MS to identify and quantify CoQ precursors and intermediates in wild-type versus UbiB-deficient strains, similar to the approach used to study the yeast CoQ pathway
Protein complex isolation: Employing affinity purification coupled with mass spectrometry to identify proteins that physically interact with UbiB
Synthetic genetic interactions: Screening for genetic interactions between UbiB and other genes in the CoQ pathway to identify functional relationships
Enzymatic assays: Developing in vitro assays to test potential substrates and biochemical activities
In yeast, the CoQ biosynthetic pathway involves conversion of tyrosine to 4-hydroxybenzoate (4-HB) through intermediates like 4-hydroxyphenylpyruvate (4-HPP) and 4-hydroxybenzaldehyde (4-HBz) . If bacterial pathways share similarities, UbiB might be involved in analogous steps, potentially working with other enzymes in a multiprotein complex similar to those observed in yeast CoQ biosynthesis .
Computational approaches provide valuable insights for guiding experimental studies of UbiB:
Homology modeling: Creating structural models based on related proteins with known structures
Molecular dynamics simulations: Analyzing protein dynamics and potential conformational changes
Substrate docking calculations: Predicting interactions with potential substrates and inhibitors
These approaches have been successfully applied to Coq6, another enzyme in the ubiquinone biosynthesis pathway . For Coq6, researchers constructed homology models of the enzyme-FAD complex, conducted molecular dynamics simulations, and performed substrate docking calculations with 3-hexaprenyl-4-hydroxyphenol (4-HP6) . This led to the identification of a putative substrate access channel and the design of mutations that could partially (G248R and L382E single mutations) or completely (G248R-L382E double-mutation) block substrate access .
A similar approach for UbiB could generate testable hypotheses about:
Potential cofactor requirements
Substrate binding sites
Critical residues for catalytic activity
Effects of mutations observed in natural variants
Studying UbiB enzymatic activity presents several challenges, including:
Substrate identification: The exact substrate of UbiB remains uncertain
Protein stability: Maintaining active protein during purification and assays
Complex formation: UbiB may function within multi-protein complexes
Membrane association: As part of ubiquinone biosynthesis, UbiB may interact with membrane components
To address these challenges, researchers can employ:
Substrate screening: Testing multiple potential substrates using analytical techniques like LC-MS
Optimized buffer conditions: Systematic testing of buffer components, pH, salt concentration, and additives to maintain protein stability
Detergent screening: Identifying appropriate detergents for solubilizing membrane-associated complexes
Co-expression strategies: Expressing UbiB with potential partner proteins to stabilize complex formation
Chemical genetics: Using specific inhibitors like those developed for COQ8 to probe function
The development of the COQ8 inhibitor TTP-UNC-CA157 demonstrates the potential of chemical tools to advance understanding of these challenging proteins . Similar approaches could be applied to UbiB to facilitate functional characterization.
Comparing bacterial UbiB with eukaryotic homologs reveals important insights into evolutionary conservation and functional divergence:
While bacterial UbiB and eukaryotic COQ8 appear to serve similar roles in ubiquinone biosynthesis, there are likely structural and functional differences reflecting their distinct cellular contexts. In eukaryotes, COQ8 proteins (COQ8A and COQ8B in humans) are known to be involved in coenzyme Q biosynthesis, and inhibitors targeting them affect this process in cells . The development of the inhibitor TTP-UNC-CA157 specifically for human COQ8 proteins has facilitated understanding their roles .
Key comparative aspects to investigate include:
Subcellular localization (mitochondrial for eukaryotic homologs)
Interaction partners within their respective biosynthetic complexes
Substrate specificity and regulatory mechanisms
Cofactor requirements and catalytic mechanisms
A systematic comparison using sequence analysis, structural modeling, and biochemical characterization would provide insights into both conserved features essential for function and species-specific adaptations.
The distribution of UbiB variants across Shewanella species could provide insights into evolutionary adaptation and functional specialization. While the search results don't specifically address UbiB distribution, they do provide a relevant parallel in the qnrA gene:
The qnrA gene, which codes for a pentapeptide repeat protein that affects quinolone and fluoroquinolone susceptibility, shows significant diversity across Shewanella species . It was detected in 22.9% of 248 genomes spanning 49 Shewanella species, with multiple variants identified including previously known variants (QnrA1, QnrA2, QnrA3, QnrA4, QnrA7, QnrA10) and 11 novel variants with 3-7 amino acid substitutions .
A similar analysis of UbiB distribution could examine:
Presence/absence patterns across Shewanella species
Sequence variations and their correlation with ecological niches
Selection pressures acting on different protein regions
Horizontal gene transfer events that might have shaped UbiB evolution
This type of analysis would contribute to understanding both the core functions of UbiB and its potential role in environmental adaptation.
UbiB's role in ubiquinone biosynthesis likely contributes significantly to Shewanella's remarkable environmental adaptations:
Shewanella loihica was isolated from iron-rich microbial mats at a hydrothermal vent and demonstrates psychrotolerance (growth at 0-42°C) . These adaptations to extreme environments likely involve specialized membrane compositions and respiratory chain components. Ubiquinones, which UbiB helps synthesize, are key components of respiratory electron transport chains that enable energy generation under various conditions.
Specific adaptations might include:
Temperature adaptation: Different ubiquinone variants may have properties optimized for function across temperature ranges
Respiratory versatility: The ability to use various electron acceptors (although S. loihica specifically showed no growth with nitrate, nitrite, DMSO or thiosulfate as electron acceptors with lactate as the electron donor)
Metal reduction capabilities: Shewanella species have demonstrated abilities to reduce metals like uranium and chromium, potentially involving respiratory chain components
Understanding UbiB's specific contribution to these adaptations would require comparative studies across growth conditions and between species with different environmental niches.
Research on UbiB has significant implications for bioremediation applications using Shewanella species:
Shewanella species have demonstrated remarkable capabilities for environmental remediation, particularly for heavy metals. They can "lessen the mobility of uranium (U) in groundwater" through transformation of U(VI) to insoluble U(IV), and assist in chromium cleanup through formation of solid oxides during Cr(VI) reduction to Cr(III) . Some species also contribute to arsenic detoxification through methylation processes .
Understanding UbiB's role in ubiquinone biosynthesis could contribute to these applications by:
Optimizing respiratory function: Enhancing electron transport efficiency for metal reduction processes
Improving stress resistance: Increasing tolerance to environmental stressors during bioremediation
Engineering enhanced strains: Creating modified Shewanella with optimized ubiquinone systems for specific remediation tasks
The connection between respiratory chain components (including ubiquinone) and metal reduction capabilities makes UbiB research potentially valuable for developing improved bioremediation strategies.
The development of specific UbiB inhibitors would significantly advance research in this field:
The recent development of the first potent COQ8 inhibitor (TTP-UNC-CA157) targeting human COQ8 proteins demonstrates a successful approach that could be adapted for bacterial UbiB . This inhibitor was identified through searching published kinase screening data, followed by screening and optimization of lead candidates .
A similar approach for UbiB could involve:
Virtual screening: Using computational models to identify potential inhibitor scaffolds
Structure-activity relationship studies: Systematically modifying promising leads to improve potency and selectivity
Co-crystal structure determination: As accomplished with COQ8A and UNC-CA157, obtaining structural data to guide inhibitor optimization
Mitochondrial targeting: If appropriate, adding groups like triphenylphosphonium to target inhibitors to specific cellular compartments
Such inhibitors would serve as valuable research tools to probe UbiB function, potentially clarifying its precise role in ubiquinone biosynthesis and enabling temporal control over its activity in experimental systems.
When designing experiments to study UbiB across different research contexts, several critical considerations should be addressed:
Protein stability and storage:
Expression systems:
Experimental controls:
Include appropriate negative controls (inactive mutants, unrelated proteins)
Use positive controls with known activity when possible
Implement internal standards for quantitative measurements
Data analysis approaches:
Apply proper statistical methods for experimental validation
Consider proteogenomic approaches that integrate multiple data types7
Implement appropriate false discovery rate controls for protein identification7
Environment-specific considerations:
Careful attention to these experimental design elements will enhance the reliability and reproducibility of UbiB research across diverse scientific contexts.